Dr. Jaime Chu is a Professor of Pediatrics and Medical Director of Pediatric Liver Transplantation at the Mount Sinai Kravis Children's Hospital and Mount Sinai's Recanati/Miller Transplantation Institute. Dr. Chu is a physician-scientist in pediatric hepatology. In addition to caring for children with liver disease and liver transplants, she leads a translational research group that focuses on how metabolism pathways regulate liver development and disease, including MASLD.

Dr. Bril is currently an Assistant Professor and Associate Scientist in the Division of Endocrinology, Diabetes and Metabolism at the University of Alabama at Birmingham (UAB). He completed medical school and 4 years of internal medicine residency at Instituto Universitario CEMIC in Buenos Aires, Argentina. Before redoing clinical training in the US, he completed a research fellowship in Endocrinology, Diabetes and Metabolism at University of Florida. He then completed internal medicine residency and endocrinology fellowship at University of Alabama at Birmingham.

Arun J. Sanyal, M.D., is a Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. At VCU, he is currently the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. He is ranked in the top 0.1% of all biomedical scientists by Stanford University rankings. Dr. Sanyal serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE and MASH track projects of FNIH, and the Liver Forum for NASH and fibrosis.

Dr. Girgrah is the Chief Wellness Officer at Ochsner Health. He leads the efforts of the Office of Professional Well-Being (OPW) at Ochsner Health which is charged with improving the professional fulfillment of their employed physicians and healthcare workforce focusing on enhanced practice efficiency and personal and team resilience and building an organizational culture that promotes provider well-being. Dr. Girgrah received both his medical degree and Ph.D. from the University of Toronto.

Dr. Ryutaro Hirose was appointed Chief of the Division of Transplant Surgery at the University of Washington and Co - Director of the UW Medicine Transplant Institute, starting his position on November 1, 2023. Dr. Hirose is a senior and well-known transplant surgeon who had previously worked at UCSF. He has extensive experience in UNOS, within the American Society of Transplant Surgeons (ASTS) , and he currently serves as the Surgical Director of the Scientific Registry of Transplant Recipients (SRTR). As a leader in transplantation, Dr.

Kristin Hatcher is a dedicated advocate for drug development and education, known for her impactful work in both fields. With a background in pharmaceutical sciences and education, Kristin has dedicated her career to bridging the gap between research and practical application, ensuring that advancements in drug development translate into real-world benefits.

Through her advocacy in drug development, Kristin actively collaborates with patients, pharmaceutical companies, researchers, and health organizations to promote innovative treatments and therapies.

Laura Bonebrake, MD, FACOG
Saint Louis University/SSM Health

Laura Bonebrake is an OB/Gyn physician currently practicing in St. Louis, Missouri. She is a strong advocate for the connections between women's health and liver health and brings her unique perspective as an OB/Gyn to this advocacy. Pregnancy and postpartum health in Intrahepatic Cholestasis of Pregnancy is her main focus due to her personal connection with this disease in her pregnancies.

Gina Bartes is an internationally recognized liver health advocate, patient leader, and founder of United Liver. Drawing on both professional expertise and lived patient and caregiver experience, she advances patient-centered solutions that improve healthcare navigation, reduce stigma, expand access to care, and elevate patient voices in research and policy. Gina serves on multiple national and international advisory groups, including the 2026 AASLD Patient Advisory Group, and is a leading voice in liver health advocacy and public health innovation.

Sophie is a two-time liver transplant recipient and transplant researcher in Salt Lake City, Utah. Diagnosed with primary sclerosing cholangitis (PSC) at the age of three, Sophie received her first liver transplant at age 15 and her second at age 21. Sophie's personal experiences inspired her to pursue an education and career in medicine. She currently works as a researcher in hepatology and pediatric organ transplantation at Intermountain Health and is in the process of applying to medical school.